Graypoint LLC’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Graypoint LLC’s Portfolio TLSIW Stock Details TLSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.08M	Hold	827,590	–	–	0.06%	201
2025 Q1	$960K	Hold	827,590	–	–	0.06%	208
2024 Q4	$910K	Buy	+827,590	New	+$983K	0.06%	205

Other funds holding TLSIW

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ACM

Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Graypoint LLC's TLSIW Position: Q2 2025 in Review

Graypoint LLC held its TriSalus Life Sciences Warrant (TLSIW) position steady in Q2 2025 at 827,590 shares worth $1.08M. The position accounts for 0.06% of the portfolio, ranked #201.

Graypoint LLC first reported a position in TLSIW in Q4 2024 and has held it in 3 quarters since. 5 funds tracked by Wall St. Rank hold TLSIW as of Q2 2025.

Graypoint LLC held 827,590 shares of TriSalus Life Sciences Warrant worth $1.08M as of Q2 2025.
Graypoint LLC left its TriSalus Life Sciences Warrant share count unchanged in Q2 2025.
TriSalus Life Sciences Warrant made up 0.06% of Graypoint LLC's portfolio in Q2 2025, its #201 holding.
Graypoint LLC first reported a position in TriSalus Life Sciences Warrant in Q4 2024 and has held it in 3 quarters since.
5 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.